Norlén P, Lindström E, Zhao C, Kitano M, Chen D, Andersson K, Håkanson R
Department of Pharmacology, Institute of Physiological Sciences, University of Lund, Lund, Sweden.
Eur J Pharmacol. 2000 Jul 14;400(1):1-10. doi: 10.1016/s0014-2999(00)00386-1.
Histamine in the oxyntic mucosa of the rat stomach occurs in mast cells (10%) and ECL cells (90%). Unlike the mast cells, the ECL cells operate under the control of gastrin. alpha-Fluoromethylhistidine, an irreversible inhibitor of the histamine-forming enzyme, histidine decarboxylase depletes ECL-cell but not mast-cell histamine. This report shows that the effectiveness by which histidine decarboxylase inhibition depletes ECL-cell histamine depends on the rate of histamine secretion. Rats received alpha-fluoromethylhistidine by continuous subcutaneous infusion for 24 h. Maximally effective doses (>/=3 mg/kg/h) inhibited histidine decarboxylase and reduced oxyntic mucosal histamine in fed rats by 80-90%. In fasted rats, the reduction was 50%. alpha-Fluoromethylhistidine greatly reduced the number of histamine-immunoreactive ECL cells (immunocytochemistry) and of secretory vesicles in the ECL cells (electron microscopy) in fed but not in fasted rats. The half-life of oxyntic mucosal histamine (determined upon histidine decarboxylase inhibition) was 2.6 h in fed rats and 19.4 h in fasted rats. The amount of histamine secreted in response to gastrin (monitored by gastric submucosal microdialysis) was greatly reduced by alpha-fluoromethylhistidine in fed rats but not in fasted rats. ECL cells were isolated from rat stomach by elutriation (80% purity). Their histamine content was determined after culture, with or without alpha-fluoromethylhistidine, in the presence of varying concentrations of gastrin. In a medium containing 10 nM gastrin, ECL cells responded to a maximally effective concentration of alpha-fluoromethylhistidine (0.1 nM) with 80% reduction in histamine content. In the absence of gastrin, ECL cells responded to alpha-fluoromethylhistidine with 45% reduction of histamine; the releasable histamine pool was unaffected. In conclusion, the combination of histidine decarboxylase inhibition and a high rate of histamine secretion will promptly exhaust the ECL-cell histamine pool, while histidine decarboxylase inhibition and a low secretion rate will affect the histamine pool much less.
大鼠胃壁细胞黏膜中的组胺存在于肥大细胞(10%)和肠嗜铬样(ECL)细胞(90%)中。与肥大细胞不同,ECL细胞在胃泌素的控制下发挥作用。α-氟甲基组氨酸是组胺形成酶——组氨酸脱羧酶的不可逆抑制剂,它可耗尽ECL细胞中的组胺,但不会影响肥大细胞中的组胺。本报告表明,组氨酸脱羧酶抑制作用耗尽ECL细胞组胺的效果取决于组胺的分泌速率。大鼠通过皮下连续输注α-氟甲基组氨酸24小时。最大有效剂量(≥3mg/kg/h)可抑制组氨酸脱羧酶,并使喂食大鼠的胃壁细胞黏膜组胺减少8~9成。在禁食大鼠中,组胺减少50%。α-氟甲基组氨酸可使喂食大鼠而非禁食大鼠中组胺免疫反应性ECL细胞的数量(免疫细胞化学法)以及ECL细胞中分泌囊泡的数量(电子显微镜法)大幅减少。胃壁细胞黏膜组胺的半衰期(在抑制组氨酸脱羧酶后测定)在喂食大鼠中为2.6小时,在禁食大鼠中为19.4小时。α-氟甲基组氨酸可使喂食大鼠而非禁食大鼠中对胃泌素作出反应而分泌的组胺量(通过胃黏膜下微透析监测)大幅减少。通过淘洗法从大鼠胃中分离出ECL细胞(纯度80%)。在含有不同浓度胃泌素的情况下,将其培养,同时添加或不添加α-氟甲基组氨酸,之后测定其组胺含量。在含有10nM胃泌素的培养基中,ECL细胞对最大有效浓度的α-氟甲基组氨酸(0.1nM)作出反应,组胺含量减少80%。在无胃泌素的情况下,ECL细胞对α-氟甲基组氨酸作出反应,组胺减少45%;可释放组胺池未受影响。总之,抑制组氨酸脱羧酶与组胺高分泌速率相结合会迅速耗尽ECL细胞的组胺池,而抑制组氨酸脱羧酶与低分泌速率相结合对组胺池的影响则小得多。